Updated Jul 16, 2026
Cross Shawn has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $628K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-25 | PCRX | Pacira BioSciences, Inc. | S — Open-market sale | 12.9K | $25.16 | $326K |
| 2026-04-25 | PCRX | Pacira BioSciences, Inc. | M — Option exercise | 12.9K | $16.45 | $213K |
| 2026-04-23 | PCRX | Pacira BioSciences, Inc. | S — Open-market sale | 1.5K | $25.01 | $38K |
| 2026-04-23 | PCRX | Pacira BioSciences, Inc. | M — Option exercise | 1.5K | $16.45 | $25K |
| 2026-04-23 | PCRX | Pacira BioSciences, Inc. | S — Open-market sale | 2.8K | $25.01 | $71K |
| 2026-04-23 | PCRX | Pacira BioSciences, Inc. | M — Option exercise | 2.8K | $16.45 | $47K |
| 2026-04-23 | PCRX | Pacira BioSciences, Inc. | S — Open-market sale | 7.7K | $25.14 | $194K |
| 2026-04-23 | PCRX | Pacira BioSciences, Inc. | M — Option exercise | 7.7K | $16.45 | $127K |
| 2026-02-13 | PCRX | Pacira BioSciences, Inc. | A — Grant or award | 49.1K | $0.00 | |
| 2024-11-18 | CYTH | Cyclo Therapeutics, Inc. | A — Grant or award | 17.2K | $0.00 | |
| 2024-11-05 | PCRX | Pacira BioSciences, Inc. | A — Grant or award | 75.0K | $0.00 |
Cross Shawn is a corporate insider — currently tracked as Chief Financial Officer of Pacira BioSciences, Inc. (PCRX). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($628K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Cross Shawn profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.